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Background: Cranial reirradiation is clinically appropriate in some cases but cumulative radiation dose to
critical normal structures remains a practical concern. The authors developed a simple technique in 3D
conformal proton craniospinal irradiation (CSI) to block organs at risk (OAR) while minimizing underdosing
of adjacent target brain tissue.
Methods: Two clinical cases illustrate the use of proton therapy to provide salvage CSI when a previously
irradiated OAR required sparing from additional radiation dose. The prior radiation plan was coregistered to
the treatment planning CT to create a planning organ at risk volume (PRV) around the OAR. Right and left
lateral cranial whole brain proton apertures were created with a small block over the PRV. Then right and left
lateral “inverse apertures” were generated, creating an aperture opening in the shape of the area previously
blocked and blocking the area previously open. The inverse aperture opening was made one millimeter
smaller than the original block to minimize the risk of dose overlap. The inverse apertures were used to
irradiate the target volume lateral to the PRV, selecting a proton beam range to abut the 50% isodose line
against either lateral edge of the PRV. Together, the 4 cranial proton fields created a region of complete dose
avoidance around the OAR. Comparative photon treatment plans were generated with opposed lateral X-ray
fields with custom blocks and coplanar intensity modulated radiation therapy optimized to avoid the PRV.
Cumulative dose volume histograms were evaluated.
Results: Treatment plans were developed and successfully implemented to provide sparing of previously
irradiated critical normal structures while treating target brain lateral to these structures. The absence of dose
overlapping during irradiation through the inverse apertures was confirmed by film. Compared to the lateral
X-ray and IMRT treatment plans, the proton CSI technique improved coverage of target brain tissue while
providing the least additional radiation dose to the previously irradiated OAR.
Conclusions: Proton craniospinal irradiation can be adapted to provide complete sparing of previously
irradiated OARs. This technique may extend the option of reirradiation to patients otherwise deemed
ineligible for further radiotherapy due to prior dose to critical normal structures.
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Salvage craniospinal irradiation (CSI) after prior cranial ra-
diation may be offered to carefully selected patients but is
not without risks, particularly if critical normal structures
have already been treated to tolerance doses. Limited cli-
nical data suggest acceptable safety and reasonable efficacy
of salvage CSI in children with recurrent, previously-
irradiated ependymoma [1], recurrent medulloblastoma
after prior CSI [2], and in other histologies with neuroaxis
dissemination after prior focal cranial radiation [3]. In
standard CSI technique with opposed lateral cranial fields,
blocking previously treated critical normal structures will
also block large volumes of target brain tissue lateral to
these structures, which leads to the possibility of tumor
reseeding in these areas and could compromise the efficacy
of treatment intended to treat the entire neuroaxis. Proton
therapy is a modality of radiation therapy which has the
physical advantage of a defined stopping point, called the
Bragg peak, with sparing of tissues beyond that point due
to the absence of exit dose [4]. We present a simple tech-
nique in proton CSI to shield critical normal structures




The authors were confronted by two clinical cases. In both
cases, written informed consent was obtained from the pa-
tient or parent for publication of this report and accom-
panying images. The first case was a 9 year old boy who
developed multilevel leptomeningeal recurrence 21 months
after 23.4 Gy (RBE) CSI for a standard risk medulloblas-
toma with a posterior fossa boost to 55.8 Gy (RBE). Review
of the prior radiation showed the 46 Gy (RBE) isodose lineCase 1
DOSE
Gy (RBE)
Figure 1 Colorwash dose distributions for prior radiation therapy are
23.4 Gy (RBE) to the neuroaxis and a boost to the posterior fossa to 55.8 G
optic chiasm (purple). Case 2, on the right, received treatment for a grade
isodose line (cyan) abutted the lateral surface of the brainstem (cyan).encroaching on the optic chiasm (Figure 1). After a good
response to initial chemotherapy, salvage proton CSI to
36 Gy (RBE) was planned, followed by a boost to 54 Gy
(RBE), provided the optic chiasm could be spared from
additional radiation dose. Dose to the brainstem was not
attenuated, based on clinical data [1] on the relative safety
of posterior fossa reirradiation, despite high cumulative
doses to the brainstem.
The second case was a 37 year old man who developed
multilevel leptomeningeal recurrence 5 months after
postoperative proton therapy to 70.2 Gy (RBE) for a pos-
terior fossa grade 3 meningioma. In the prior radiation
plan, the 62 Gy (RBE) isodose line abutted the surface of
the brainstem (Figure 1). Salvage proton CSI to 36 Gy
(RBE) was planned, followed by a boost to 54 Gy (RBE),
provided the previously treated right lateral surface of
the brainstem could be spared from further radiation. In
this case, the treating physician felt that the short inter-
val from prior radiation therapy did not allow for any
additional radiation dose to be delivered to the portion
of the brainstem which had previously received 62 Gy
(RBE), and the cumulative surface dose to the brainstem
should be limited to 62 Gy (RBE).
Delineation of avoidance structures
For both cases, the prior radiation treatment plans were
coregistered to the new treatment planning simulation CT
so that the prior delivered cranial radiation dose could be
understood in relation to the new treatment planning scan,
and a composite dose plan could be created. The organs at
risk (OARs) were delineated using a coregistered treatment
planning magnetic resonance image. For the first case, the
treating physician (JB) delineated the optic chiasm and
created a planning organ at risk volume (PRV) composedCase 2
DOSE
Gy (RBE)
shown. Case 1, on the left, received treatment for medulloblastoma,
y (RBE). The 46 Gy (RBE) isodose line (purple) encroached upon the
III posterior fossa meningioma to 70.2 Gy (RBE). The 62 Gy (RBE)
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dose line of the retreatment plan should abut this avoidance
structure. For the second case, the treating physician (MM)
used the coregistered prior treatment plan to delineate the
lateral length of the brainstem which had previously
received 62 Gy (RBE) and used an anisotropic expansion of
1 cm laterally and 3 mm in the anterior to posterior and
cranio-caudal direction around this portion of the brain-
stem to define the PRV, intending that the 50% iso-
dose line of the retreatment plan should abut this
avoidance structure.
The difference in PRV definition between the two
cases reflected the individual best clinical judgment of
the physicians involved, and consideration of individual
treatment goals and uncertainties in the region of the
inverse aperture. In the second case, recurrent tumor in
the posterior fossa was in much closer proximity to the
OAR, prompting a smaller PRV expansion in the anter-
ior posterior direction, where PRV avoidance was pro-
vided by the aperture edge and uncertainties were
limited to potential organ motion of the OAR and
patient setup uncertainties. However in the lateral direc-
tion, OAR avoidance was dependent on the reliability of
distal proton beam blocking. In addition to lateral





Figure 2 Apertures shapes created for salvage craniospinal irradiation
block over the optic chiasm are shown on the left, and on the right, the in
the bottom row, for case 2, the whole brain apertures with a block over th
aperture to irradiate the target lateral to the previously irradiated brainstemtissue heterogeneity in the proton beam path (in the sec-
ond case including the mastoid air cells) was considered
in creating a larger PRV expansion to provide an additional
safety margin around the OAR.
Proton treatment planning and delivery
Patients were immobilized in the supine position with a
custom alpha-cradle and thermoplastic head mask, acqui-
ring a treatment planning CT scan with 2 mm slice thick-
ness from the top of the head to the proximal femurs. We
have previously described our technique for supine proton
CSI using a custom carbon-fiber table [5]. At our institu-
tion, patient positioning is accomplished on a robotic
patient positioner with six degrees of freedom. Orthogonal
kilovoltage image sets are taken every day for every treat-
ment field, using bony anatomic landmarks as registration
points to calculate required shifts to duplicate the patient
position from the time of simulation. On-line verification
of patient positioning is made by a physician prior to
treatment of each field.
To treat the cranial portion of the target, right and left
lateral cranial apertures were generated to treat the whole
brain. A small block was extended from the closest edge of
the aperture to block the previously delineated avoidance






. On the top row, for case 1, the whole brain apertures with a small
verse aperture to irradiate the target lateral to the optic chiasm. On
e brainstem are shown on the left, and on the right, the inverse
surface. Aperture outlines have been enhanced for visibility.
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each of these fields delivering 50% of the fractional dose.
These fields blocked the PRV and created plan dosimetry
very similar to two lateral photon fields with a custom
block over the PRV, leaving a dose shadow lateral to the
blocked PRV.
To fill in these dose shadows and treat more of the target
brain tissue lateral to the PRV, an inverse aperture was
created. Taking the original aperture shape, an auto-
contouring feature was used so that the area originally deli-
neated as a block over the PRV was instead reversed as the
aperture opening. The original aperture was now made
inverse: the open cranial areas were now blocked and the
previously blocked area over the PRV was now open. These
inverse apertures were also both treated daily and each
delivered 100% of the fractional dose, irradiating the target
volume lateral to the structure of concern. The energy or
range of the proton beam through the inverse apertures
were selected so that the distal 50% isodose line of the
beam through the right side would abut the right edge of
the previously defined PRV and similarly for the beam
through the left inverse aperture to abut the left edge
of the PRV.
The first aperture sets with blocks and the inverse
apertures shared the same isocenter for patient setup
and created a radial matchline as the block edge of the
first aperture was the field edge of the inverse aperture.
To address the treatment dosimetry and delivery uncer-
tainties created by this radial matchline, the inverse aper-
ture opening around the PRV was made 1 mm smaller
than the aperture block over the PRV, deliberately intro-
ducing a 1 mm gap at the margin of the abutting open
and blocked fields. The selection of 1 mm was made
a posteriori in the same way that some practitioners
introduce a small gap between abutting cranial and
spinal fields in photon craniospinal irradiation.Figure 3 Colorwash dose distributions for salvage craniospinal irradia
blocks, and in the center, the dose from the lateral inverse apertures. On th
sagittal planes showing the zone of dose avoidance around the previouslyComparative treatment plans
For comparison to the proton treatment plan, the same
CT and structure set were used to generate a conventional
photon plan and an IMRT treatment plan addressing the
cranial portion of the target with avoidance of the pre-
viously developed PRVs. To compare the intracranial
target coverage, a planning target volume (PTV) was
created for evaluation (cranial PTV 36 Gy) consisting of
the intracranial target volume minus the PRV. The
conventional photon plan utilized two opposed lateral cra-
nial fields with 6 MV photons and a custom cerrobend
block over the PRV on both fields to achieve sparing of
the OAR. The IMRT treatment plan utilized 9 coplanar
fields with the gantry at 0, 30, 60, 125, 160, 200, 230, 300,
and 300 degrees. Priority during IMRT optimization was
given to PRV avoidance so that the dose profile to the
PRV and maximum dose would attempt to match the
proton treatment plan, while maximizing the coverage of
the cranial PTV 36 Gy.
Results
Salvage proton craniospinal treatment plans were deve-
loped and successfully implemented to provide sparing of
previously irradiated critical normal structures while treat-
ing target brain lateral to these structures. The dose color-
wash for the lateral fields with blocks, the inverse apertures,
and the composite dose are shown for each case in Figures 3
and 4. The clinical setup was assessed by the treating phy-
sician to verify light fields through the open and inverse
apertures on the patient immobilization mask, confirming
no overlap of fields. On the first day of treatment, film
dosimetry was performed to assess the junction of the open
and inverse cranial apertures to ensure no dose overlap. An
example of the film dosimetry from the second case is
shown in Figure 5. After initial follow-up of nine months
from the completion of reirradiation, both patients are alivetion for case 1. On the left, the dose from the lateral fields with
e right, the composite dose distribution in transverse, coronal and
treated optic chiasm.
Figure 4 Colorwash dose distributions for salvage craniospinal irradiation for case 2. On the left, the dose from the lateral fields with
blocks, and in the center, the dose from the lateral inverse apertures. On the right, the composite dose distribution in transverse, coronal and
sagittal planes showing the zone of dose avoidance around the previously treated surface of the brainstem.
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system toxicities.
Comparative treatment plans are demonstrated for each
case in Figures 6 and 7. Using lateral photon cranial fields
with custom cerrobend blocking, a dose distribution nearly
identical to that with lateral proton cranial fields with
blocking of the OAR is achieved, both blocking volumes of
target brain tissue lateral to the OAR. Using a 9 field cop-
lanar intensity modulated photon radiation treatment
(IMRT) plan, a zone of central dose attenuation was cre-
ated around the PRV, although due to the physical proper-
ties of x-rays, it was not possible to achieve a zone of zero
radiation at the OAR with multi-field IMRT due to exitFigure 5 Film dosimetry from patient case 2 is reproduced,
showing the dose exposure after irradiation through both the
lateral blocked field and inverse aperture field. Film dosimetry
was taken at the first day of treatment to verify the small radial gap
between fields and the absence of dose overlap.dose from multiple beam angles. Quantitative comparison
of the treatment plans may be made in the dose volume
histograms in Figures 8 and 9, while Table 1 provides com-
parison of target volume coverage and dose to the OAR
for the comparative treatment plans. Compared to
both the lateral X-ray plan and the 9-field coplanar
IMRT plan, the lateral proton reirradiation technique
provided improved coverage of the cranial PTV 36 Gy
while adding the least additional radiation dose to the
previously irradiated OAR of concern.
Discussion
While cranial reirradiation may be clinically appropriate
in some cases, cumulative radiation dose to critical normal
structures remains a practical concern. Clinical experience
and animal data demonstrate that normal brain tissues, in-
cluding the brainstem and spinal cord, exhibit substantial
recovery from prior radiation over time [6]. The relatively
low risk of radiation necrosis and myelopathy seen in
patients reirradiated for brainstem gliomas, supratentorial
gliomas, and metastatic brain disease may be explained by
the relatively short median survival of these patients [7].
Conversely, in patients with a good prognosis or longer
anticipated survival, central nervous system toxicity may
be seen, even in patients with a long latency between ini-
tial cranial radiation and retreatment [8]. Practitioners and
patients must deliberate carefully on the risk benefit ratio
of further radiation therapy, define risk tolerance and
acceptable and unacceptable toxicities, and within those
parameters make best estimates of acceptable additional
dose tolerance of critical normal structures.
Dose attenuation to the previously irradiated upper
cervical spinal cord during salvage CSI for ependymoma
was described by Merchant et al. [1] by blocking this re-
gion after delivery of an additional 16.2 Gy, limiting the
Figure 6 Comparative treatment plans for case 1. The dose distribution is shown in colorwash and the 12 Gy (33.3%) isodose line is
delineated in white, while the 30.6 Gy (85%) isodose line is delineated in orange.
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here, critical normal structures were judged to be at or
near maximum acceptable cumulative dose. In this set-
ting, if reirradiation is offered, blocking these structures
on lateral fields will exclude a large volume of target
brain tissue in order to shield the normal structure.
Our technique provides a relatively simple method to
provide a region of central dose sparing while minimizing
the volume of target brain tissue that is excluded from
reirradiation. In both patient cases, sparing the structure
of concern required only two additional sets of apertures
and compensators, and since additional treatment angles
were not required, only modestly impacted the treatment
duration.
Alternatives to this approach include the use of intensity
modulated radiation therapy or volumetric modulated arc
therapy to create a zone of dose attenuation around the
structure of concern, similar to hippocampal avoidance
during whole brain radiation [9]. Wei and colleagues [3]
reported a series of 6 patients with prior cranial irradiation
who received salvage craniospinal irradiation to 36 Gy
using IMRT to attenuate dose to the previously irradiated
brain tissue. No dosimetric data were provided to evaluateFigure 7 Comparative treatment plans for case 2. The dose distribution
delineated in white, while the 30.6 Gy (85%) isodose line is delineated in othe degree of sparing of previously irradiated tissues or to
provide comparison to alternative techniques. Compared to
photon techniques, proton therapy has dosimetric advan-
tages in the spinal portion of craniospinal irradiation [10]
which eliminates acute radiotherapy toxicity that would be
expected from radiation dose that would otherwise exit into
the viscera anterior to the spine, and is expected to trans-
late to reductions in late toxicity of therapy [11]. Using our
technique of blocking structures and then “plugging” dose
in lateral to those structures through inverse apertures, pro-
ton CSI can also achieve areas of central dose avoidance,
and could be modified to produce regions of dose attenu-
ation if desired, for example to treat previously irradiated
tissues at a lower fractional dose than radiation-naïve
volumes. It is anticipated that the implementation of
intensity modulated proton therapy will allow for gene-
ration of similar regions of dose avoidance or attenuation
without the requirement of patient specific hardware used
in this technique.
Some may question the value of employing proton
therapy, which is presently more expensive than photon-
based radiation techniques, for salvage craniospinal
irradiation. In our opinion, there are simply insufficientis shown in colorwash and the 12 Gy (33.3%) isodose line is
range.
Figure 8 Dose volume histogram for case 1. The dose delivered
in reirradiation to the cranial PTV 36 Gy is compared for three
treatment options: lateral X-ray fields with blocks, a 9-field coplanar
intensity modulated radiation (IMRT) plan, and a lateral proton fields
with blocks and inverse apertures. The lateral proton plan provides
improved coverage of the cranial PTV 36 Gy. The dose to the optic
chiasm from the initial radiation treatment plan is shown, labeled
“d”, while the cumulative dose to the optic chiasm from prior
radiation and reirradiation is compared by the same three treatment
plans. The lateral proton plan incurred virtually no additional dose to
the optic chiasm, and the cumulative dose was less than with the
lateral X-ray plan or the IMRT plan.
Figure 9 Dose volume histogram for case 2. The dose delivered
in reirradiation to the cranial PTV 36 Gy is compared for three
treatment options: lateral X-ray fields with blocks, a 9-field coplanar
intensity modulated radiation (IMRT) plan, and a lateral proton fields
with blocks and inverse apertures. The lateral proton plan provides
improved coverage of the cranial PTV 36 Gy. The dose to the
brainstem from the initial radiation treatment plan is shown, labeled
“d”, while the cumulative dose to the brainstem from prior radiation
and reirradiation is compared by the same three treatment plans.
The lateral proton plan incurred minimal additional dose to the
brainstem, and the cumulative dose was less than with the lateral
X-ray plan or the IMRT plan.
Table 1 Dosimetric evaluation of treatment plans
Case 1
Cranial PTV 36 Gy, Dose from Reirradiation
X-ray IMRT Proton
PTV covered by 65% IDL (23.4 Gy) 91.0% 95.8% 99.1%
PTV covered by 90% IDL (32.4 Gy) 82.1% 86.1% 96.1%
PTV covered by 95% IDL (34.2 Gy) 64.2% 76.8% 94.8%
Minimum Dose to PTV 3.2 Gy 9.9 Gy 0.9 Gy
Mean Dose to PTV 32.9 Gy 34.6 Gy 36.0 Gy
Dose covering 95% of PTV 9.8 Gy 25.2 Gy 34.0 Gy
Cumulative Dose to Optic Chiasm from Both Courses of Radiation
Prior RT X-ray IMRT Proton
Mean dose 41.0 Gy 45.6 Gy 51.0 Gy 41.0 Gy
Maximum point dose 43.2 Gy 47.9 Gy 54.0 Gy 43.9 Gy
Case 2
Cranial PTV 36 Gy, Dose from Reirradiation
X-ray IMRT Proton
PTV covered by 65% IDL (23.4 Gy) 92.9% 96.9% 99.9%
PTV covered by 90% IDL (32.4 Gy) 88.5% 87.9% 98.1%
PTV covered by 95% IDL (34.2 Gy) 85.7% 76.6% 96.1%
Minimum Dose to PTV 3.6 Gy 11.5 Gy 6.5 Gy
Mean Dose to PTV 33.9 Gy 34.8 Gy 35.8 Gy
Dose covering 95% of PTV 12.8 Gy 28.1 Gy 34.7 Gy
Cumulative Dose to Brainstem from Both Courses of Radiation
Prior RT X-ray IMRT Proton
Dose to 0.5 cc 59.7 Gy 64.4 Gy 70.9 Gy 61.2 Gy
Dose to 1 cc 57.8 Gy 62.1 Gy 68.6 Gy 59.3 Gy
Maximum point dose 65.6 Gy 71.2 Gy 78.1 Gy 71.2 Gy
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ratio of employing more conformal radiation techniques
in this setting. Although clinical data continues to
emerge from multiple institutions, reirradiation remains
a highly individualized clinical challenge. In the judgment
of the treating physicians, both of the cases presented here
were anticipated to be potential long-term survivors and
to meet the constraints placed on the OARs, large
volumes of the cranial PTV 36 Gy would have been un-
treated or underdosed with other techniques, potentially
increasing the risk of CNS failure.
Limitations of this technique include the inability to
create a “floating” block, and a minimum field size for
the inverse aperture in order to preserve the desired
Bragg peak and accurately model proton dosimetry [12].
Additionally, extra attention to patient setup and
immobilization is required due to the risk of intrafrac-
tional motion and dose overlap during treatment of the
inverse aperture. We chose to minimize this risk by
creating the inverse aperture 1 mm smaller than the
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to ensure no dose overlap occurred. An alternative or
adjunct to utilizing a small radial gap would be to
feather the radial field junction by developing multiple
sets of blocked and inverse apertures of varying sizes to
move the location of field abutment during the treat-
ment course in the same way that cranial and spine field
junctions are feathered during a CSI course.Conclusions
Proton craniospinal irradiation can be adapted to pro-
vide dose sparing of previously treated critical normal
structures. In this technique, lateral proton cranial field
apertures block the structure of concern while inverse
apertures treat the portion of target brain lateral to the
organ at risk that would otherwise be underdosed. This
technique provided more complete coverage of the
intracranial target volume than could be achieved using
lateral photon fields with blocks or with IMRT and may
extend the option of reirradition to patients otherwise
deemed ineligible for further radiotherapy due to prior
dose to critical normal structures.
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